12. Stockholders' Equity

2006 Omnibus Long-Term Incentive Plan

In conjunction with the Company's initial public offering, the board of directors and the Company's shareholders approved the 2006 Omnibus Long-Term Incentive Plan, or the 2006 Plan, on December 2, 2005. The 2005 Stock Option and Incentive Plan was terminated when the 2006 Plan became effective, immediately after the closing of the initial public offering.

A portion of the options and restricted shares granted to employees vest based on certain performance conditions being satisfied by the Company. Performance-based stock options are tied to the Company's annual performance against pre-established internal targets and the actual payout under these awards may vary from zero to 100% of an employee's target payout, based upon the Company's actual performance during the previous twelve months. The performance-based stock options are also subject to vesting requirements and generally vest when the performance condition has been satisfied. The fair value for stock options granted during the period was estimated at the grant date using the Black-Scholes option pricing model, as described in Note 2, and the fair value of restricted shares granted is based on the closing price of the shares on the grant date. Compensation cost is recognized when the performance condition has been satisfied or when it becomes probable that the performance condition will be satisfied.

Under the 2006 Plan, as amended, 10,000,000 shares were available for issuance. At September 30, 2009, there were 5,189,996 shares remaining reserved for issuance in connection with awards under the 2006 Plan. During fiscal year 2010, the Company granted options to purchase 624,566 shares to employees and directors with exercise prices between $9.05 and $13.96, and options to purchase 75,467 shares were forfeited. During fiscal year 2010, the Company granted 699,410 restricted shares to employees and directors at prices ranging from $9.05 to $13.96, and 45,026 restricted shares were forfeited. At September 30, 2010, there were 3,986,513 shares remaining reserved for issuance in connection with awards under the 2006 Plan. During fiscal year 2011, the Company granted options to purchase 321,072 shares to employees and directors with exercise prices between $14.30 and $17.02, and options to purchase 73,591 shares were forfeited. During fiscal year 2011, the Company granted 736,340 restricted shares to employees and directors at prices ranging from $12.88 to $25.52, and 150,112 restricted shares were forfeited. During fiscal year 2012, the Company granted options to purchase 181,783 shares to employees and directors with exercise prices between $31.37 and $42.31, and options to purchase 78,148 shares were forfeited. During fiscal year 2012, the Company granted 633,647 restricted shares to employees and directors at prices ranging from $31.37 to $52.55, and 138,052 restricted shares were forfeited. During the twelve months ended September 30, 2012, the Company issued 100,000 restricted shares to a non-employee that vest based on performance conditions. During fiscal year 2013, the Company granted options to purchase 171,994 shares to employees and directors with exercise prices between $29.47 and $46.72, and options to purchase 32,244 shares were forfeited. During fiscal year 2013, the Company granted 997,857 restricted shares to employees and directors at prices ranging from $29.47 to $42.47, and 403,083 restricted shares were forfeited. During the twelve months ended September 30, 2013, the Company issued 335,000 restricted shares and cancelled 281,500 restricted shares to a non-employee that vest based on performance conditions. During fiscal year 2014, the Company granted options to purchase 437,755 shares to employees and directors with exercise prices between $21.53 and $31.37, and options to purchase 181,094 shares were forfeited. During fiscal year 2014, the Company granted 1,040,748 restricted shares to employees and directors at prices ranging from $13.11 to $38.09, and 250,586 restricted shares were forfeited. At September 30, 2014, there were 772,227 shares remaining reserved for issuance in connection with awards under the 2006 Plan. The maximum number of shares subject to options or stock appreciation rights that can be awarded under the 2006 Plan to any person is 1,000,000 per year. The maximum number of shares that can be awarded under the 2006 Plan to any person, other than pursuant to an option or stock appreciation right, is 700,000 per year. These shares and options generally vest over a period of one to four years conditioned on continued employment for the incentive period.

The 2006 Plan permits the granting of options to purchase shares of common stock intended to qualify as incentive stock options under the Internal Revenue Code and stock options that do not qualify as incentive stock options ("non-qualified stock options"). The exercise price of each stock option may not be less than 100% of the fair market value of the common stock on the date of grant. However, if a grant recipient, who holds at least 10% of the common stock of the Company, receives an incentive stock option, the exercise price of such incentive stock option may not be less than 110% of the fair market value of the common stock on the date of grant. The term of each stock option is fixed by the compensation committee and may not exceed 10 years from the date of grant.

The compensation committee may also award under the 2006 Plan:

restricted stock, which are shares of common stock subject to restrictions;

stock units, which are common stock units subject to restrictions;

dividend equivalent rights, which are rights entitling the recipient to receive credits for dividends that would be paid if the recipient had held a specified number of shares of common stock;

stock appreciation rights, which are rights to receive a number of shares or, in the discretion of the compensation committee and subject to applicable law, an amount in cash or a combination of shares and cash, based on the increase in the fair market value of the shares underlying the right during a stated period specified by the compensation committee;

unrestricted stock, which are shares of common stock granted without restrictions as a bonus; and

performance and annual incentive awards, ultimately payable in common stock or cash, as determined by the compensation committee (the compensation committee may grant multi-year and annual incentive awards subject to achievement of specified goals tied to business criteria set forth in the 2006 Plan).

Share Repurchase Program

The Company's Board of Directors has approved the repurchase of up to $101.9 million in shares under a share repurchase program. Under the program, the Company is authorized to repurchase the issued and outstanding shares of common stock. Share repurchases may be made through open market purchases, privately negotiated transactions or otherwise, at times and in such amounts as management deems appropriate. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements and other market conditions. The repurchase program may be discontinued or suspended at any time, and will be funded using the Company's available cash. The Company's Board of Directors reviews the share repurchase program periodically, the last such review having occurred in February 2014. A summary of the Company's share repurchase activity from fiscal year 2009 to the year ended September 30, 2014 is as follows:

Fiscal Year Period	Total Number of Shares Purchased		Average Price Paid per Share		Total Cash Paid for Shares Purchased		Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs(1)
2009		707,462	$	5.50	$	3,874,000	$	6,126,000
2010		1,225,019	$	11.53		14,471,000		1,655,000
2011		229,575	$	15.39		3,541,000		18,114,000
2012		505,067	$	59.41		30,000,000		18,114,000
2013		—		—		—		31,000,000
2014		2,962,978	$	15.90	$	44,873,000	$	5,127,000

(1)

On December 2, 2008, the Company's Board of Directors approved a share repurchase program, under which the Company was authorized to repurchase up to $10.0 million of the issued and outstanding shares of Company common stock. On each of February 2, 2010, November 30, 2010 and May 31, 2011, the Company's Board of Directors approved an additional $10.0 million for the share repurchase program. On May 17, 2012, the Company's Board of Directors approved an additional $30.0 million for the share repurchase program. On December 12, 2013, the Company's Board of Directors approved an additional approximately $12.9 million for the share repurchase program. On February 5, 2014, the Company's Board of Directors approved an additional $19.0 million for the share repurchase program.

Stock Option Activity

A summary of the Company's stock option activity for the years ended September 30, 2014, 2013, and 2012 is as follows:

	Options			Weighted- Average Exercise Price
Options outstanding at September 30, 2011		2,894,547		$	11.55
Options granted		181,783			34.42
Options exercised		(1,322,387	)		11.72
Options canceled		(78,148	)		12.72

Options outstanding at September 30, 2012		1,675,795			13.84
Options granted		171,994			35.76
Options exercised		(223,139	)		11.35
Options canceled		(32,244	)		18.67

Options outstanding at September 30, 2013		1,592,406			16.46
Options granted		437,755			22.41
Options exercised		(383,160	)		10.83
Options canceled		(181,094	)		18.14

Options outstanding at September 30, 2014		1,465,907			19.50


Options exercisable at September 30, 2014		890,103			16.15

The following table summarizes information about options outstanding at September 30, 2014:

	Options Outstanding
Range of Exercise Price	Number Outstanding		Weighted- Average Remaining Contractual Life		Weighted- Average Exercise Price
$3.00 - 8.00		148,448		4.20	$	7.38
$8.23 - $46.72		1,317,459		6.52		20.87

		1,465,907		6.10		19.50

The following table summarizes information about options exercisable at September 30, 2014:

	Options Exercisable
Range of Exercise Price	Number Exercisable		Weighted- Average Remaining Contractual Life		Weighted- Average Exercise Price
$3.00 - $46.72		890,103		4.38	$	16.15

The following table summarizes information about assumptions used in valuing options granted:

	Year ended September 30
	2014		2013		2012
Dividend yield		—		—		—
Expected volatility		50.9% - 60.6%		51.8% - 60.6%		60.4	%
Risk-free interest rate		0.1% - 1.2%		0.1% - 1.0%		0.6	%
Expected forfeiture rate		19.7% - 22.8%		19.7%		19.0	%

The intrinsic value of outstanding and exercisable options at September 30, 2014 was approximately $1,797,000 and $1,658,000, respectively, based on a stock price of $13.75 on September 30, 2014.

The weighted average grant date fair value of options granted during 2014, 2013 and 2012 was $7.89, $12.98, and $13.77, respectively.

The intrinsic value of options exercised at September 30, 2014, 2013, and 2012 was $1,119,000, $4,943,000, and $50,899,000, respectively.

Restricted Share Activity

A summary of the Company's restricted share activity for the years ended September 30, 2014, 2013, and 2012 is as follows:

	Restricted Shares			Weighted- Average Fair Value
Unvested restricted shares at September 30, 2011		1,294,082		$	13.13
Restricted shares granted		633,647			34.05
Restricted shares vested		(390,068	)		12.53
Restricted shares canceled		(138,052	)		15.70

Unvested restricted shares at September 30, 2012		1,399,609			22.51
Restricted shares granted		997,857			36.97
Restricted shares vested		(450,514	)		21.18
Restricted shares canceled		(403,083	)		35.39

Unvested restricted shares at September 30, 2013		1,543,869			28.89
Restricted shares granted		1,040,748			18.78
Restricted shares vested		(436,204	)		24.72
Restricted shares canceled		(250,586	)		23.87

Unvested restricted shares at September 30, 2014		1,897,827			24.96

For the years ended September 30, 2014, 2013 and 2012, the Company recorded stock-based compensation of $12,605,000, $13,379,000, and $12,117,000, respectively. The total costs related to unvested awards, not yet recognized, as of September 30, 2014 was $41,214,000, which will be recognized over the weighted average vesting period of 25.8 months.